These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28004607)

  • 21. [Legal requirements for health protection from the European viewpoint--uniform regulations or reciprocal recognition of public health norms?].
    Schlüter P
    Zentralbl Hyg Umweltmed; 1996 Dec; 199(2-4):105-18. PubMed ID: 9409912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Similarities and differences in the oncology drug approval process between FDA and European Union with emphasis on in vitro companion diagnostics.
    Senderowicz AM; Pfaff O
    Clin Cancer Res; 2014 Mar; 20(6):1445-52. PubMed ID: 24634467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study.
    Hwang TJ; Sokolov E; Franklin JM; Kesselheim AS
    BMJ; 2016 Jun; 353():i3323. PubMed ID: 27352914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening potential intakes of colour additives used in non-alcoholic beverages.
    Tennant DR
    Food Chem Toxicol; 2008 Jun; 46(6):1985-93. PubMed ID: 18353518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction to in vitro diagnostic device regulatory requirements.
    Day J
    Methods Mol Biol; 2013; 949():103-12. PubMed ID: 23329438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Composition, labelling, and safety of food supplements based on bee products in the legislative framework of the European Union - Croatian experiences.
    Vujić M; Pollak L
    Arh Hig Rada Toksikol; 2015 Dec; 66(4):243-9. PubMed ID: 26751855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biosimilars: A consideration of the regulations in the United States and European union.
    Daller J
    Regul Toxicol Pharmacol; 2016 Apr; 76():199-208. PubMed ID: 26732800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Navigating through orphan medicinal product regulations in EU and US--similarities and differences.
    Tiwari J
    Regul Toxicol Pharmacol; 2015 Feb; 71(1):63-7. PubMed ID: 25497996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of the work of the EU Reference Laboratory supporting the authorisation process of feed additives in the EU. [corrected].
    von Holst C; Robouch P; Bellorini S; González de la Huebra MJ; Ezerskis Z
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016; 33(1):66-77. PubMed ID: 26540604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
    Pflieger M; Bertram D
    Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidance for pediatric use in prescription information for novel medicinal products in the EU and the US.
    Christiansen H; De Bruin ML; Frokjaer S; Hallgreen CE
    PLoS One; 2022; 17(4):e0266353. PubMed ID: 35377911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Food supplements : Legal requirements, borderline issues and other aspects].
    Noble P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Mar; 60(3):260-267. PubMed ID: 28070624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public health implications of differences in U.S. and European Union regulatory policies for breast implants.
    Zuckerman D; Booker N; Nagda S
    Reprod Health Matters; 2012 Dec; 20(40):102-11. PubMed ID: 23245415
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sudan and other illegal dyes--food adulteration].
    Gajda J; Switka A; Kuźma K; Jarecka J
    Rocz Panstw Zakl Hig; 2006; 57(4):317-23. PubMed ID: 17713194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EU alerting and reporting systems for potential chemical public health threats and hazards.
    Orford R; Crabbe H; Hague C; Schaper A; Duarte-Davidson R
    Environ Int; 2014 Nov; 72():15-25. PubMed ID: 25023642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulatory aspects of nanotechnology in the agri/feed/food sector in EU and non-EU countries.
    Amenta V; Aschberger K; Arena M; Bouwmeester H; Botelho Moniz F; Brandhoff P; Gottardo S; Marvin HJ; Mech A; Quiros Pesudo L; Rauscher H; Schoonjans R; Vettori MV; Weigel S; Peters RJ
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):463-76. PubMed ID: 26169479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Food additives used in meat processing according to the Polish and European Union legislation.
    Uradziński J; Weiner M
    Pol J Vet Sci; 2003; 6(2):173-6. PubMed ID: 12817787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similarities and Differences of International Practices and Procedures for the Regulation for Active Substance Master Files/Drug Master Files of Human Use: Moving Toward Regulatory Convergence.
    Matsuhama M; Takishita T; Kuribayashi R; Takagi K; Wakao R; Mikami K
    J Pharm Pharm Sci; 2016; 19(2):290-301. PubMed ID: 27518176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent trends in the use of food additives in the United Kingdom.
    Saltmarsh M
    J Sci Food Agric; 2015 Mar; 95(4):649-52. PubMed ID: 24789520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vigilance systems in the EU and the US: a short comparison.
    van Eeckhoven E
    Med Device Technol; 1994; 5(6):27-9. PubMed ID: 10172088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.